Effect of oral magnesium sachet versus placebo on treatment of post-dural puncture headache in pregnant women candidate for cesarean section

Effect of oral magnesium sachet versus placebo on treatment of post-dural puncture headache in pregnant women candidate for cesarean section: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N433

Enrollment

130

Registered

2022-07-06

Start date

2022-07-23

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache. Other headache syndromes

Interventions

Intervention 1: Intervention group: Magnesium sachet 400 mg once a day for 3 days. Intervention 2: Control group: Placebo sachet once a day for 3 days.

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age of 15 to 45 years Pregnant women candidate for cesarean section

Exclusion criteria

Exclusion criteria: Preeclampsia History of chronic headache Renal failure

Design outcomes

Primary

Measure	Time frame
Headache. Timepoint: On the first, third and fifth days after cesarean section. Method of measurement: Using Visual Analog Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKamran Borhani Naeini

Hamedan University of Medical Sciences

kamranborhani@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026